These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21694730)

  • 1. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
    Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
    J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinohivin: specific amino acid residues essential for anti-HIV activity.
    Takahashi A; Inokoshi J; Tsunoda M; Suzuki K; Takenaka A; Sekiguchi T; Omura S; Tanaka H
    J Antibiot (Tokyo); 2010 Nov; 63(11):661-5. PubMed ID: 20842142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
    Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete.
    Takahashi A; Inokoshi J; Chiba H; Omura S; Tanaka H
    Arch Biochem Biophys; 2005 May; 437(2):233-40. PubMed ID: 15850563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
    Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
    Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
    Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
    Chiba H; Inokoshi J; Okamoto M; Asanuma S; Matsuzaki Ki ; Iwama M; Mizumoto K; Tanaka H; Oheda M; Fujita K; Nakashima H; Shinose M; Takahashi Y; Omura S
    Biochem Biophys Res Commun; 2001 Mar; 282(2):595-601. PubMed ID: 11401502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli.
    Inokoshi J; Chiba H; Asanuma S; Takahashi A; Omura S; Tanaka H
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1261-5. PubMed ID: 11243871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
    Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
    J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV entry by carbohydrate-binding proteins.
    Balzarini J
    Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.
    Matoba N; Husk AS; Barnett BW; Pickel MM; Arntzen CJ; Montefiori DC; Takahashi A; Tanno K; Omura S; Cao H; Mooney JP; Hanson CV; Tanaka H
    PLoS One; 2010 Jun; 5(6):e11143. PubMed ID: 20559567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
    Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
    Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
    Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
    Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic study of the interaction of the anti-HIV lectin actinohivin with the α(1-2)mannobiose moiety of gp120 HMTG.
    Suzuki K; Ohbayashi N; Jiang J; Zhang X; Hoque MM; Tsunoda M; Murayama K; Tanaka H; Takénaka A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Sep; 68(Pt 9):1060-3. PubMed ID: 22949194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1-2)mannobiose moiety of gp120.
    Hoque MM; Suzuki K; Tsunoda M; Jiang J; Zhang F; Takahashi A; Ohbayashi N; Zhang X; Tanaka H; Omura S; Takénaka A
    Acta Crystallogr D Biol Crystallogr; 2012 Dec; 68(Pt 12):1671-9. PubMed ID: 23151632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
    Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
    Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.